KLRK1 and neoplasm: Moreover, the cytotoxic activities of Vγ9Vδ2 T-cells were significantly reduced by an anti-NKG2D mAb blockade, see Figure 2A, and Figure S1B, indicating NKG2D-dependent recognition of tumor cells by γδ T-cells.